Search

everythinglearnresearchcommunity

for

Search:↓

Nasopharyngeal carcinoma is a common cancer in Indonesia, with risk factors including genetics, diet, and Epstein-Barr virus, and is treated with advanced radiotherapy.

Trichilemmal carcinoma is rare, usually benign after removal, but needs close follow-up due to recurrence risks.

A reliable method was developed to measure dutasteride in tablets accurately and consistently.

Personalized treatment plans combining natural and synthetic approaches are important for managing alopecia effectively.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

The model and estimator can predict drug exposure in kidney transplant patients well.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Many adult women experience unexplained excessive hair shedding, often starting before age 40.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Pharmacists play a crucial role in personalized care and medication management.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

The treatment is safe and shows promise for metastatic breast cancer.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

MK-5108 is safe and shows potential against tumors, especially alone.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.